ProQomics is pioneering high-throughput proteoform quantitation through a cutting-edge mass spectrometry platform. Our technology is designed to provide accurate, large-scale quantification of proteoforms and post-translationally modified proteins, empowering researchers and pharmaceutical companies to gain deeper insights into the molecular mechanisms of diseases. By combining multiplexed immuno arrays with high-resolution mass spectrometry, ProQomics enables faster, more detailed protein profiling—critical for drug discovery and biomarker development. Our products include innovative reagents, internal standards, and front-end instruments that streamline proteomics workflows, transforming how proteoforms are analyzed in research and industry.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://proqomics.com
Proqomics Questions
Proqomics's website is http://proqomics.com
Proqomics's LinkedIn profile is https://www.linkedin.com/company/proqomics
Proqomics has
2 employees.
View email and phone details for 2
employees at Proqomics.
Proqomics's industry is
Biotechnology Research
Proqomics's top competitors are
Ird Software,
Johnson & Johnson Medtech,
Schooling,
Encon Evaporators,
Jecí-Naiã,
Nine Diagnostics,
Adeptrix Corporation,
Immigrants™,
Delta 9 Analytical,
Armatus Bio, Inc..
Proqomics's categories are Biotechnology Research
Proqomics's founding year is 2024
